Clinical Handbook of Psychotropic Drugs for Children and Adolescents
Hogrefe Publishing (Verlag)
978-0-88937-550-5 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
New in this edition:
* Drugs for ADHD thoroughly revised and updated
* Antipsychotics with many changes and additions, including fully revised lab tests/monitoring
* Antidepressants fully revised, including new sections on irreversible MAO-B inhibitor and serotonin modulator and stimulator (SMS), revised frequency of adverse effects table and switching strategies recommendations
* Hypnotics completely revised
* Mood stabilizers fully revised and a new toxicity comparison table added
* Drugs of abuse and treatment of substance use disorder comprehensively revised
* New unapproved treatments with significant updates, including: anti-inflammatories and NMDA agents in anxiety/OCD, cannabis use, and irritability of autism
* New agents include: brexpiprazole, cariprazine, hypnotic suvorexant, tasimelteon, vortioxetine
* New formulations and trade names include: Adasuve, Alprazolam Intensol, Aptensio XR, Aristada, Belbuca, Belsomra, Brintellix, Bunavail, Cotempla XR-ODT, Dyanavel XR, Eldepryl, EMSAM, Evekeo, Hemangeol, Hetlioz, Innopran XL, Invega Trinza, Khedezla, Metadol-D, Mydayis, NyQuil, Quillichew ER, Quillivant XR, Rexulti, Som-Pam, Tegretol (liquid), Trintellix, Versacolz, Vraylar, Vyvanse, Zelapar, Zenzedi
The Clinical Handbook of Psychotropic Drugs for Children and Adolescents has become a standard reference and working tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other mental health professionals.
* Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment options
* Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, nursing implications, and much more - all you need to know for each class of drug
* Potential interactions and side effects summarized in comparison charts
* With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
* Clearly written patient and caregiver information sheets for download as printable PDF files
This book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.
Dean Elbe; BScPharm, PharmD, BCPP; Children's & Women's Health Centre of British Columbia, Vancouver, BC, Canada. Tyler R. Black; BSc, MD, FRCPC; British Columbia Children's Hospital, Vancouver, BC, Canada. Ian R. McGrane; PharmD, BCPS, BCPP; Skaggs School of Pharmacy, University of Montana, Missoula, MT, USA. Ric M. Procyshyn; BScPharm, MSc, PharmD, PhD; British Columbia Mental Health & Addictions Research Institute, Vancouver, BC, Canada.
Preliminary
Psychiatric Disorders in Children and Adolescents
Attention-Deficit/Hyperactivity Disorder (ADHD) * Major Depressive Disorder (MDD) * Disruptive Mood Dysregulation Disorder (DMDD) * Bipolar Disorder (BD) * Schizophrenia * ANXIETY DISORDERS * Separation Anxiety Disorder * Generalized Anxiety Disorder (GAD) * Social Anxiety Disorder * Panic Disorder * Specific Phobia * Obsessive-Compulsive Disorder (OCD) * TRAUMA- AND STRESSOR-RELATED DISORDERS * Posttraumatic Stress Disorder (PTSD) * TIC DISORDERS * Tourette's Disorder * Autism Spectrum Disorder (ASD) * DISRUPTIVE, IMPULSE-CONTROL, AND CONDUCT DISORDERS * Conduct Disorder (CD) Oppositional Defiant Disorder (ODD)
Drugs for ADHD
Psychostimulants * Atomoxetine * Comparison of Drugs for ADHD * 2 Agonists * Augmentation Strategies in ADHD
Antidepressants
Selective Serotonin Reuptake Inhibitors (SSRI) * Norepinephrine Dopamine Reuptake Inhibitor (NDRI) * Serotonin Norepinephrine Reuptake Inhibitor (SNRI) * Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) * Serotonin-1A Partial Agonist/Serotonin Reuptake Inhibitor (SPARI) * Serotonin Modulator and Stimulator (SMS) * Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) * Nonselective Cyclic Antidepressants * Monoamine Oxidase Inhibitors * Reversible Inhibitor of MAO-A (RIMA) * Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs) * Irreversible MAO-B Inhibitor * Effects of Antidepressants on Neurotransmitters/Receptors * Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors * Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses * Antidepressant Doses and Pharmacokinetics * Switching Antidepressants * Antidepressant Augmentation Strategies
Electroconvulsive Therapy (ECT)
Antipsychotics
"Second-Generation" Antipsychotics/SGAs * "Third-Generation" Antipsychotic/ TGA * "First-Generation" Antipsychotics/FGAs * Effects of Antipsychotics on Neurotransmitters/Receptors* Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptors * Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses * Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) * Comparison of Long-Acting IM Antipsychotics * Switching Antipsychotics * Antipsychotic Augmentation Strategies
Antipsychotic-Induced Extrapyramidal Side Effects (EPSE) and Their Management
Extrapyramidal Side Effects of Antipsychotics * Treatment Options for Extrapyramidal Side Effects * Effects on Extrapyramidal Symptoms * Comparison of Agents for Treating Acute Extrapyramidal Side Effects * Doses and Pharmacokinetics of Agents for Treating Acute Extrapyramidal Side Effects
Anxiolytic (Antianxiety) Agents
Benzodiazepines * Comparison of the Benzodiazepines * Buspirone
Hypnotics/Sedatives
Comparison of Hypnotics/Sedatives
Mood Stabilizers
Lithium * Anticonvulsants * Comparison of Anticonvulsants * Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic Doses
Drugs/Substances of Abuse
Alcohol * Stimulants * Hallucinogens * Opioids * Inhalants/Aerosols * Sodium Oxybate (Gamma-Hydroxybutyrate - GHB) * Flunitrazepam (Rohypnol) * Nicotine/Tobacco
Treatment of Substance Use Disorders
Disulfiram * Acamprosate * Naltrexone * Methadone * Buprenorphine * Pharmacotherapy for Nicotine/Tobacco Use Dependence
Unapproved Treatments of Psychiatric Disorders
Adrenergic Agents * Cholinergic Agents * Dopaminergic Agents * GABA Agents/Anticonvulsants * Miscellaneous * NMDA Agents
Natural Health Products
Glossary
Drug Use in Pregnancy and Effects on Breast Milk
Patient and Caregiver Information Sheets
Index of Drugs
| Erscheinungsdatum | 19.12.2018 |
|---|---|
| Verlagsort | Toronto |
| Sprache | englisch |
| Maße | 279 x 216 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
| Medizin / Pharmazie ► Pharmazie | |
| Schlagworte | Pediatrics • Psychopharmacology • Psychotropic drugs |
| ISBN-10 | 0-88937-550-X / 088937550X |
| ISBN-13 | 978-0-88937-550-5 / 9780889375505 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
